QGQing Gu

Qing Gu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Qing Gu has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Aiyun Shan

    Shenzhen Futian District Traditional Chinese Medicine Hospital, No. 6001 in North Central Avenue, Futian District, Shenzhen, 518033 Guangdong China

    1 shared publication
  • Jiayu Sun

    Shenzhen Futian District Traditional Chinese Medicine Hospital, No. 6001 in North Central Avenue, Futian District, Shenzhen, 518033 Guangdong China

    1 shared publication
  • Li Zhang

    Shenzhen Futian District Traditional Chinese Medicine Hospital, No. 6001 in North Central Avenue, Futian District, Shenzhen, 518033 Guangdong China

    1 shared publication
  • Ruipeng Zhang

    Key Lab for New Drugs Research of TCM, Research Institute of Tsinghua University in Shenzhen, Shenzhen, Guangdong China

    1 shared publication
  • Xiaohui Lv

    Shenzhen Futian District Traditional Chinese Medicine Hospital, No. 6001 in North Central Avenue, Futian District, Shenzhen, 518033 Guangdong China

    1 shared publication
  • Zhigang Cai

    Shenzhen Futian District Traditional Chinese Medicine Hospital, No. 6001 in North Central Avenue, Futian District, Shenzhen, 518033 Guangdong China

    1 shared publication

Latest Publications

  • Open Access

    Interaction between peroxisome proliferator-activated receptor gamma polymorphism and obesity on type 2 diabetes in a Chinese Han population

    by Xiaohui Lv, Li Zhang, Jiayu Sun, Zhigang Cai, Qing Gu, Ruipeng Zhang, Aiyun Shan

    The aim of this study was to investigate the association of four single nucleotide polymorphisms (SNPs) of peroxisome proliferator-activated receptor gamma (PPARG) with type 2 diabetes mellitus (T2DM) risk and additional role of gene-obesity interaction. Four SNPs were selected for genotyping in the case–control study: rs1805192, rs709158, rs3856806 and rs4684847. Generalized multifactor dimensionality reduction (GMDR) model and logistic regression was used to examine the interaction between SNP and obesity on T2DM, odds ratio (OR) and 95% confident interval (95% CI) were calculated. T2DM risk was significantly higher in individuals with rs1805192-G allele (p < 0.05). The carriers of G allele of the rs1805192 polymorphism revealed increased T2DM risk than those with CC variants (CG + GG versus CC, adjusted OR (95% CI) 1.76 (1.45–2.06), p < 0.001). T2DM risk was also significantly higher in individuals with rs3856806-T allele (p < 0.05). The carriers of T allele of the rs3856806 polymorphism revealed increased T2DM risk than those with CC variants (CT + TT versus CC, adjusted OR (95% CI) 1.25 (1.17–1.76), p < 0.001). There was a significant two-locus model (p = 0.0107) involving rs1805192 and obesity. Obese subjects with CG or GG genotype have the highest T2DM risk, compared to subjects with CC genotype and normal BMI (OR 2.40, 95% CI 1.68–3.63). Our results support an important association between rs1805192 and rs3856806 minor allele (G allele) of PPARG and increased T2DM risk, the interaction analysis shown a combined effect of G- obesity interaction between rs1805192 and obesity on increased T2DM risk.